EcoDrugPlus

Ensembl ID : HMEL015627
Gene Symbol: -
External references: -
127 Possible Orthologues:

Ensembl ID : HMEL015689
Gene Symbol: -
External references: -
117 Possible Orthologues:

Ensembl ID : HMEL015745
Gene Symbol: -
External references: -
549 Possible Orthologues:

Ensembl ID : HMEL015746
Gene Symbol: -
External references: -
262 Possible Orthologues:

Ensembl ID : HMEL015748
Gene Symbol: -
External references: -
549 Possible Orthologues:

Ensembl ID : HMEL015755
Gene Symbol: -
External references: -
36 Possible Orthologues:

Ensembl ID : HMEL015764
Gene Symbol: -
External references: -
127 Possible Orthologues:

Ensembl ID : HMEL015773
Gene Symbol: -
External references: -
536 Possible Orthologues:

Ensembl ID : HMEL015848
Gene Symbol: -
External references: -
49 Possible Orthologues:

Ensembl ID : HMEL015850
Gene Symbol: -
External references: -
174 Possible Orthologues:

Ensembl ID : HMEL015873
Gene Symbol: -
External references: -
345 Possible Orthologues:

Ensembl ID : HMEL015886
Gene Symbol: -
External references: -
668 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).